Previous 10 | Next 10 |
WOBURN, Mass., Nov. 21, 2022 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that President and CEO Oliver Peoples, Ph.D. will present a corporate overview at the C...
Yield10 Bioscience, Inc. (YTEN) Q3 2022 Earnings Conference Call November 14, 2022 4:30 PM ET Company Participants Lynne Brum – Vice President of Planning and Corporate Communications Oliver Peoples – President and Chief Executive Officer Kristi Sne...
The following slide deck was published by Yield10 Bioscience, Inc. in conjunction with their 2022 Q3 earnings call. For further details see: Yield10 Bioscience, Inc. 2022 Q3 - Results - Earnings Call Presentation
Yield10 Bioscience press release ( NASDAQ: YTEN ): Q3 GAAP EPS of -$0.71 misses by $0.05 . Revenue of $0.1M (+11.1% Y/Y) misses by $0.03M . The company continues to estimate total net cash usage for the full year ended December 31, 2022 in a range of $12.0 - $1...
-Grower contracts in place for winter 2022/2023 -Development of herbicide tolerance traits in Camelina on track -Collaboration with Rothamsted Research for omega-3 technology extended through 2023 -Management will host a conference call today at 4:30 p.m. (ET) to revie...
Yield10 Bioscience ( NASDAQ: YTEN ) is scheduled to announce Q3 earnings results on Monday, November 14th, after market close. The consensus EPS Estimate is -$0.66 and the consensus Revenue Estimate is $0.13M. Over the last 3 months, EPS estimates have seen 0 upward ...
-Advancing development of herbicide tolerant Camelina- -Building commercial seed inventory available to growers in 2023 and beyond- WOBURN, Mass., Nov. 10, 2022 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), a...
WOBURN, Mass., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that the Company will report its third quarter 2022 financial results and provide a corporate...
WOBURN, MA / ACCESSWIRE / October 6, 2022 / Yield10 Bioscience, Inc. (NASDAQ:YTEN) ("Yield10" or the "Company"), an agricultural bioscience company, has been invited to present at the MicroCap Rodeo presents: The Windy City Roundup 2022 investor conference, which is being held in-person on O...
WOBURN, Mass., Oct. 05, 2022 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that Willie Loh, Ph.D., was named to the Company’s Board of Directors effective Octobe...
News, Short Squeeze, Breakout and More Instantly...
Yield10 Bioscience Inc. Company Name:
YTEN Stock Symbol:
NASDAQ Market:
- Nufarm to pay up to USD $5 million in consideration for the license -The parties will negotiate the sale of essentially all of Yield10’s assets to Nufarm WOBURN, Mass. and WEST SACRAMENTO, Calif., July 17, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (OTC:YTEN) (“...
WOBURN, Mass. and HARPENDEN, United Kingdom, June 17, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (OTC:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company, today announced that U.K.-based Rothamsted Research Limited (“Rothamsted”)...
- EPA approved an amendment to the label of INTERLINE herbicide to include Camelina -The supplemental label now allows application of INTERLINE for over-the-top weed control in Camelina WOBURN, Mass., May 23, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (OTC:YTEN) (“Yield1...